Stripe Pre-IPO Shares: What Accredited Investors Should Know in 2026
.png)
Brian Nichols is the co-founder of Angel Squad, a community where you’ll learn how to angel invest and get a chance to invest as little as $1k into Hustle Fund's top performing early-stage startups
Key takeaways
- Stripe's last priced round was a $50 billion Series I in March 2023, which was actually a 52% down round from its $95 billion 2021 peak.
- Since then, tender offers have re-rated the company from about $65 billion in early 2024 to $159 billion in February 2026. Secondary units now trade near $61.91.
- Stripe generated roughly $5.1 billion in revenue in 2024, up 28%, and grew to an estimated $6.9 billion in 2025. That puts the secondary at about 22x revenue.
- Here is the kicker: Stripe doubled its free cash flow to $2.2 billion in 2024. This is a profitable company, which is rare at this stage.
- Stripe allows direct stock transfers, but most small-check access still runs through SPVs, so the usual structural risks apply.
Stripe is the payments backbone for a huge slice of the internet, and its secondary story is one of the more instructive in the private markets. The company took a brutal haircut in 2023, cutting its own valuation from $95 billion to $50 billion in a priced round. Then, quietly, through a series of tender offers rather than new rounds, the market marked it back up. The February 2026 tender cleared at a $159 billion valuation. Units that changed hands near $35 a year and a half ago now trade around $62.
So which number is real, the stale $50 billion round or the $159 billion tender? That question is the whole game, and answering it takes actual math rather than vibes. Let's get into it.
What the Numbers Actually Say
Entry price versus the last round. This is where Stripe is unusual. The last priced round set a $50 billion valuation at $20.13 per share in 2023. The secondary now trades near $61.91, a 208% premium to that round. On its face that looks insane. But the priced round is stale and was itself a down round, so it is a bad anchor. The better reference is the tender history: $65 billion in early 2024, $70 billion that November at $27.51, $91.5 billion in early 2025, and $159 billion in February 2026 at $63.00 per share. The secondary at $61.91 is trading right at that latest tender level. So you are not paying a wild premium to a real transaction. You are paying roughly what large holders and buyers cleared at a few months ago.
Revenue multiple, trailing. Stripe did about $5.1 billion in revenue in 2024, growing 28%, and an estimated $6.9 billion in 2025. Against a market cap near $154 billion, that is roughly 22x trailing revenue. On the $159 billion tender, about 23x. On the stale $50 billion round, only about 7x, which is exactly why hindsight makes that down round look like a gift to whoever bought it. For a steady compounder, low-20s revenue multiple is a real price but not a bubble price, and it sits in reasonable territory when you weigh it against how multiples actually shape returns.
Revenue multiple, forward. If Stripe keeps compounding in the 25% to 35% range, revenue lands somewhere around $8.5 to $9 billion next year, which pulls the forward multiple down toward the high teens. That is the quiet strength of a business this size still growing at this rate.
Peer comparison. Put Stripe's 22x next to Shield AI, a defense name trading closer to 46x on actual revenue with no profitability and a recent target miss. The two could not be more different. Stripe is the boring, profitable, cash-generating compounder at a digestible multiple. Shield AI is the high-multiple, high-variance growth bet. Neither is automatically the better buy, but if you value certainty and cash flow, Stripe is the cleaner profile by a wide margin.
Profitability and margins. This is the headline most data screens bury. Stripe doubled its free cash flow to $2.2 billion in 2024 on $5.1 billion of revenue. That is a free cash flow margin north of 40%, which is extraordinary for a company still growing at nearly 30%. A profitable, cash-generating business does not need to raise, cannot be forced into another down round, and can pick its own timeline for going public. That is real downside protection, and it is the most important fact in Stripe's favor.
Revenue trajectory. The line is steady and boring in the best way: roughly $3.2 billion in 2022, $4.0 billion in 2023, $5.1 billion in 2024, and about $6.9 billion in 2025. Revenue per employee sits above $500,000 across roughly 15,000 people. This is a machine, not a moonshot.
The Demand Story Is Softer Than the Markup Suggests
Here is a wrinkle worth flagging. Even after the run to a $159 billion tender, Notice reports investor demand currently sitting below the supply of available shares. That tells you the re-rating was driven by tenders and large holders resetting the price, not by a frenzy of new buyers piling in. It also means you may have room to be patient rather than paying up in a scramble.
This is the supply-and-demand lens our very own Hustle Fund GP, Elizabeth Yin, applies to every valuation. As she frames it, price comes down to the supply of a tranche against the demand from investors. Stripe's tender-driven markup shows how a handful of large transactions can reset a company's whole valuation narrative, even while day-to-day secondary demand stays soft. Read that as a reason to focus on the business math rather than the momentum.
How You Would Actually Buy It (And Why That Matters)
Stripe allows direct stock transfers, which is a genuine advantage. It is possible to hold actual shares rather than a synthetic claim. Still, most accredited investors writing normal checks will access it through a special purpose vehicle pooled by a syndicate, because individual blocks are large. Our SPV strategy guide walks through how that works. Two risks still matter.
Risk one: forward purchase contracts are synthetic exposure. Some sellers offer a forward rather than actual shares. A forward is a contract promising to deliver shares or their value later, usually at a liquidity event. You are not on the cap table. You hold a promise. If the seller defaults, or the transfer is blocked, or the seller's structure unwinds, you become an unsecured creditor of a counterparty instead of a Stripe shareholder. With no committed IPO date, that counterparty risk can ride for years. Confirm whether you are buying shares or a forward, and if it is a forward, know exactly who is on the other side.
Risk two: second and third-layer SPVs stack fees and hide your cost basis. Often the vehicle you are offered is not the one holding the stock. It is an SPV that bought into another SPV that holds the position. Each layer adds a management fee and carry, and each layer blurs your real entry price. On a name where part of the appeal is the reasonable 22x multiple, two or three layers of fees can quietly turn a fair entry into an expensive one. Ask how many layers sit between your check and the shares, and what each charges. Bring the same discipline you would to protective terms on any deal, and use your access to real deal flow to compare terms across offers rather than taking the first one.
.jpg)
The Bottom Line
Stripe is the rare pre-IPO name where the fundamentals do the heavy lifting. It is profitable, growing near 30%, generating billions in free cash flow, and trading at a multiple that is expensive but defensible against a real recent transaction. The main risks are not about the business. They are about the structure you use to buy it and the patience you need for an exit that has no set date. That is a much more comfortable place to be than betting on a growth ramp that has to go perfectly.
This is the kind of deal where a serious community earns its keep, because separating a stale headline valuation from the price real transactions are clearing at, and structuring the entry so fees do not eat the return, is exactly what gets missed going solo. That is a big part of why Angel Squad exists. It is a community of more than 2,500 investors across 50-plus countries who have collectively put over $30 million into 70-plus startups, operating under a strict no-a-holes policy with access to the top 1% of deal flow. Hustle Fund is an early-stage fund, but Squad members see the full spectrum, from pre-seed through pre-IPO names like Stripe, with the context to pressure-test a deal before committing. Learn more at hustlefund.vc/squad.

Frequently Asked Questions
What is Stripe's current valuation? Stripe's last priced round set a $50 billion valuation in March 2023. Since then, tender offers have re-rated it upward, with the February 2026 tender clearing near $159 billion. Notice puts its real-time market cap around $154 billion.
What is Stripe's secondary share price? Secondary units trade near $61.91 as of early June 2026, in line with the $63.00 price from the February 2026 tender. That figure is an algorithmic consensus rather than a guaranteed execution price.
How much revenue does Stripe generate? Stripe reported roughly $5.1 billion in revenue in 2024, up 28%, and grew to an estimated $6.9 billion in 2025. That places the secondary at about 22x trailing revenue.
Is Stripe profitable? Yes. Stripe doubled its free cash flow to $2.2 billion in 2024 on $5.1 billion of revenue, a free cash flow margin above 40%. Profitability at this scale is rare among pre-IPO companies.
Why did Stripe's valuation fall and then recover? Stripe cut its valuation from $95 billion to $50 billion in a 2023 priced round during the broader tech reset. Since then, tender offers rather than new rounds have marked it back up to $159 billion as growth and cash flow strengthened.
Can I buy Stripe stock directly? Stripe permits direct stock transfers, which is a plus. In practice, most accredited investors access it through a special purpose vehicle, which carries fees and structural considerations worth reviewing before committing.







.png)